Outlook Therapeutics, Inc. Common Stock
€0.36322
EUR
Last updated on --.
24h volume301.32M
24h highest0.61712 EUR
24h lowest0.26165 EUR
24h Price movement+36.14%
OTLK recent prices
24 Hours
+36.14%+€0.096398
30 days
+55.09%+€0.13513
60 days
+51.32%+€0.091923
90 days
+2.01%+€0.0074881
Key data
Previous close0.26673 EUR
Market cap28.40M EUR
Volume301.32M
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-0.33567 EUR
Net income (FY)-41.02M EUR
Revenue (FY)365.74K EUR
Last report dateMay 15, 2026
About Outlook Therapeutics, Inc. Common Stock
HeadquartersISELIN
Employees (FY)17.00
Revenue per employee (FY)21.51K EUR
Net income per employee (FY)-2.41M EUR
Listed onNasdaq
OTLK conversion tables
 |  |
|---|---|
| 0.5 OTLK | 0.18161 EUR |
| 1 OTLK | 0.36322 EUR |
| 5 OTLK | 1.816 EUR |
| 10 OTLK | 3.632 EUR |
| |
|---|---|
| 0.5 EUR | 1.376 OTLK |
| 1 EUR | 2.753 OTLK |
| 5 EUR | 13.76 OTLK |
| 10 EUR | 27.53 OTLK |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
OTLK is trading at €0.36322, +36.14% over the last 24 hours. Track live moves on the price chart at the top of this page.
The OTLK stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. OTLK is currently trading at €0.36322, +36.14% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on OTLK price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. OTLK's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from OTLK; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against OTLK's historical range and other companies in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.
Outlook Therapeutics, Inc. Common Stock's market cap is currently 28.40M EUR. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume301.32M
24h highest0.61712 EUR
24h lowest0.26165 EUR
24h Price movement+36.14%
Start trade with OTLK Perpetual
Sign up to trade